Switch theme

🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Pharma Diagnostics & Analytics

Benchmark revenue and EBITDA valuation multiples for public comps like Bio-Techne, Sepax Technologies, Oxford Nanopore Techs, Proteomics International and Bioventix.

Explore Sector Coverage Start Free Trial

Pharma Diagnostics & Analytics

See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
Company EV EV/LTM Revenue EV/LTM EBITDA
Wantai BioPharm logo Wantai BioPharm
$10.1B n/a n/a
Bio-Techne logo Bio-Techne
$8.4B 6.9x 19.9x
Adaptive Biotech logo Adaptive Biotech
$1.7B 8.4x -27.2x
Oxford Nanopore Techs logo Oxford Nanopore Techs
$1.5B 5.4x -10.2x
Sepax Technologies logo Sepax Technologies
$928M n/a n/a
Bioventix logo Bioventix
$186M 10.1x 13.2x
Avacta Group logo Avacta Group
$183M 2457.5x -5.3x
Genomictree logo Genomictree
$168M n/a n/a
Biohit logo Biohit
$46.5M 2.8x 13.8x
Proteomics International logo Proteomics International
$39.0M 15.5x -9.6x
AnteoTech logo AnteoTech
$21.5M n/a n/a
Ulisse Biomed logo Ulisse Biomed
$20.0M 15.3x -9.1x
GenIP logo GenIP
$6.0M n/a n/a
Nautilus Biotechnology logo Nautilus Biotechnology
-$9.1M n/a 0.1x
Zomedica logo Zomedica
-$24.2M -0.9x n/a

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.

Start Free Trial 🎦 Book a Call